Total Return chart Amplia Therapeutics Limited

Stocks

Delayed Australian S.E. 00:28:30 2026-09-02 EDT			5-day change	1st Jan Change
0.1400 ^AUD	+3.70%		-3.45%	-6.67%

08-03	Amplia Therapeutics to Evaluate Combination Therapy for Non-Small Cell Lung Cancer in Collaboration With Eli Lilly; Shares Rise 7%	MT
08-03	Amplia Therapeutics to Evaluate Combination Therapy for Non-Small Cell Lung Cancer in Collaboration With Eli Lilly	MT

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.